Cannabinol (CBN) isolate in a withe to yellowish powder form, with a minimum purity of 98%. This CBN isolate is produced in an EU-GMP compliant facility within the European Union. EU-GMP certification is in progress and is expected in the second half of 2021.
COA’s and samples are available upon request. Please contact us if you want more information about this CBN isolate.
Cannabinol – CBN
CBN is a non-intoxicating cannabinoid and research shows its antibacterial, anti-inflammatory and anticonvulsant properties. The compound is currently used in formulations developed for the treatment of glaucoma, rare genetic skin conditions and pain management, including clinical trials.
Chemically synthesized CBN shows zero psychoactive effects, and our cannabinol isolate is produced by converting naturally extracted CBD isolate and mimicking the processes observed in nature. Our proprietary technology allows us to achieve large amounts of this minor cannabinoid with quality exceeding 98% purity. Cannabinol also seems to display healthy synergistic (entourage) effects when used in the presence of CBD and other minor cannabinoids.